Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | TP53 | P04637 | 1/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | CA12 | O43570 | 2/20 | 0.57 |
| ▸ | CA9 | Q16790 | 2/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4182294 | 1.00 | CYP3A4 (0.65) | CYP3A4MEN1KMT2ATP53CYP2C9 | |
| SCHEMBL7744452 | 1.00 | CYP3A4 (0.65) | CYP3A4MEN1KMT2ATP53CYP2C9 | |
| SCHEMBL30618501 | 1.00 | CYP3A4 (0.65) | CYP3A4MEN1KMT2ATP53CYP2C9 | |
| SCHEMBL16689628 | 1.00 | CYP3A4 (0.65) | CYP3A4MEN1KMT2ATP53CYP2C9 | |
| SCHEMBL7945964 | 1.00 | CYP3A4 (0.65) | CYP3A4MEN1KMT2ATP53CYP2C9 | |
| SCHEMBL18022553 | 1.00 | CYP3A4 (0.65) | CYP3A4MEN1KMT2ATP53CYP2C9 | |
| SCHEMBL31103681 | 1.00 | CYP3A4 (0.65) | CYP3A4MEN1KMT2ATP53CYP2C9 | |
| SCHEMBL22710592 | 1.00 | CYP3A4 (0.65) | CYP3A4MEN1KMT2ATP53CYP2C9 | |
| SCHEMBL22073058 | 1.00 | CYP3A4 (0.65) | CYP3A4MEN1KMT2ATP53CYP2C9 | |
| SCHEMBL12870233 | 0.99 | CYP3A4 (0.63) | CYP3A4MEN1KMT2ATP53CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022241417-A1 | METHODS AND COMPOSITIONS FOR EXTENDING ORGAN AND TISSUE PRESERVATION | THE GENERAL HOSPITAL CORPORATION (US) | 2022-11-17 | — | — | WO | disclosed |
| US-20090215710-A1 | CARBOHYDRATE BASED TOLL-LIKE RECEPTOR (TLR) ANTAGONISTS | RELIANCE LIFE SCIENCES PVT. LTD. (IN) | 2009-08-27 | — | — | US | disclosed |
| US-6339162-B1 | SOLVOLYSIS OF 4-ACETYLOXYPHENYL-ACETYL-.BETA.-D-GLUCOPYRANOSIDE DERIVATIVE, NEUTRALIZATION WITH ACID, CRYSTALLIZATION OF ARBUTIN OR ITS DERIVATIVE | NISSHIN PHARMA INC. (JP) | 2002-01-15 | — | — | US | disclosed |
| EP-1043321-A1 | Process for the preparation of tetrahydropyran derivatives | Nisshin Flour Milling Co., Ltd. (JP) | 2000-10-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090215710-A1 | CARBOHYDRATE BASED TOLL-LIKE RECEPTOR (TLR) ANTAGONISTS | TLR4, TLR1, TLR2 | CYP3A4 1915/4885MEN1 4480/4885KMT2A 1661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.